11/20/2019 · Find the latest Intec Pharma Ltd. (NTEC) stock quote, history, news and other vital information to help you with your stock trading and investing. 9/28/2019 · Zacks Investment Research cut shares of Intec Pharma (NASDAQ:NTEC) from a buy rating to a hold rating in a report issued on Tuesday morning, Zacks.com reports. According to Zacks, “Intec Pharma Ltd. is a biopharmaceutical company. The company focused on developing drugs through proprietary Accordion Pill platform technology.

Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. NTEC: Intec Pharma Ltd. EPS. Get the latest EPS stock quote information from Zacks Investment Research.

Stocks Analysis by Zacks Investment Research covering: Intec Pharma Ltd. Read Zacks Investment Research's latest article on Investing.com

Get today's Intec Pharma Ltd stock price and latest NTEC news as well as Intec Pharma real-time stock quotes, technical analysis, full financials and more. NTEC Stock Message Board for Investors. Intec Pharma Ltd. Stock Price, News and Company Updates. Message Board Total Posts: 10 eVal develop dynamic web-based apps and valuation tools. This page provides a list of peer compay data, include corporation or group name and equity ticker. Analyzing Sono-Tek (Otcmkts:SOTK) stock? View SOTK's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Welcome to the Compound Trading Swing Trading Stock Report Friday May 18, 2018 (Part B). The Wall Street of Stock Trading and Investing Financial Community Site for Traders and Investors. Free stock quotes, news, research, message postings, stock picks, chat rooms, and financial content.

Exploring Intec Pharma (NASDAQ:NTEC) stock? View NTEC's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at 

Dec 11, 2019 According to Zacks, analysts expect that Martin Midstream Partners will report full-year earnings of ($4.54) per share for the current financial  Nov 27, 2017 ER10-208-000, it carried over the 11.1 percent ROE from the NTEC. growth rates; no beta, stock price stability, price growth persistence, 

Biotech Leading in Q4: Best ETFs & Stocks - www.zacks.com.. $GERN $HAIR $INFI $MITK $NTEC $VCEL Week 11 Breakout Forecast Short Term Picks Give 

Intec Pharma Ltd. Ordinary Shares (NTEC) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Technical stock forecast for NTEC: Intec Pharma Ltd. holds several negative signals and 30 day high of the NTEC stock price was $0.69 and low was $0.44.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Intec Pharma Ltd. (NTEC): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research

Wall Street brokerages expect Intec Pharma Ltd (NASDAQ:NTEC) to post ($0.28) earnings per share for the current quarter, according to Zacks. Zero analysts have issued estimates for Intec Pharma’s earnings, with estimates ranging from ($0.33) to ($0.25). 11/20/2019 · Find the latest Intec Pharma Ltd. (NTEC) stock quote, history, news and other vital information to help you with your stock trading and investing. 9/28/2019 · Zacks Investment Research cut shares of Intec Pharma (NASDAQ:NTEC) from a buy rating to a hold rating in a report issued on Tuesday morning, Zacks.com reports. According to Zacks, “Intec Pharma Ltd. is a biopharmaceutical company. The company focused on developing drugs through proprietary Accordion Pill platform technology. 11/14/2019 · Investors need to pay close attention to Intec Pharma (NTEC) stock based on the movements in the options market lately. Canopy Growth's (CGC) recent

Intec Pharma (NASDAQ:NTEC) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note issued to investors on Thursday, Zacks.com reports. According to Zacks, “Intec Pharma Ltd. is a biopharmaceutical company. The company focused on developing drugs through proprietary Accordion Pill platform technology. Stock screener for investors and traders, financial visualizations. NTEC Forecast and Technical Stock Analysis Sell candidate since 2019-12-20 Loss -4.50% PDF Intec Pharma Ltd. gained 2.11% in the last trading day ( Monday, 30th Dec 2019 ), rising from $0.47 to $0.48 During the day the stock fluctuated 9.07% from a day low at $0.44 to a day high of $0.48 .